Is the price fair?
What CBT's price assumes
Cabot Corporation trades at 16.0× earnings against 28.3× for the median Specialty Chemicals name, cheaper than its own group.
16.0
Trailing P/E · Specialty Chemicals median 28.3 · cheaper than the typical name in its group
- Price / sales
- 1.09
Price / sales · as of 2026-Q1
- Free cash flow yield
- 9.1%
Free cash flow yield · Specialty Chemicals median 3.9%
- Growth the price implies
- −2.4%
Growth the price implies · The price pays for −2.4% free cash flow growth a year for a decade; the business has delivered +50% a year over the last three.
Details›
- Price / book2026-Q1
- 2.49
- EV / EBIT2026-Q1
- 8.04
- EV / sales2026-Q1
- 1.26
- Basic Materials median P/E153 names
- 22.8
- Specialty Chemicals median P/E37 names
- 28.3
- Free cash flow, trailing twelve months
- $432M
- Market capitalisation
- $4.74B
- 3-year revenue growth
- −5.7%
- 3-year free cash flow growth
- +50%
| Method | Per share |
|---|---|
| Its own P/E history, lower quartile | $61.91 |
| Its own P/E history, median | $66.78 |
| Its own P/E history, upper quartile | $82.83 |
| 52-week range | $57.64 – $93.09 |
| Today | $84.59 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #24 of 36 by Smart Score